Safety Profile of Ceftazidime –Avibactam: Pooled Data from the Adult Phase II and Phase III Clinical Trial Programme

ConclusionThe observed safety profile of ceftazidime –avibactam across infection types is consistent with the established safety profile of ceftazidime monotherapy and no new safety findings were identified. This analysis supports the use of ceftazidime–avibactam as a treatment option in adults with cUTI, cIAI and NP, including VAP.
Source: Drug Safety - Category: Drugs & Pharmacology Source Type: research